已收录 273091 条政策
 政策提纲
  • 暂无提纲
Hypolipemic statins and new therapeutcal trends
[摘要] Statins are the most used drugs for the treatment of hyperlipidemia in primary and secondary prevention, with the aim of decreasing the levels of plasmatic cholesterol- lipoproteins. Owing to their structural similarity to the substrate HMG-CoA (3-hydroxy-3-methylglutaryl-CoA), they inhibit the HMG-CoA reductase enzyme, disrupting the cholesterol biosynthesis. Currently, six therapeutic statins are available: lovastatin (Mevacor) and pravastatin (Pravachol), which are natural, sinvastatin (Zocor), a semi-synthetic derivative, and the totally synthetic statins, fluvastatin (Lescol), atorvastatin (Lipitor) and rosuvastatin (Crestor). Recent investigations have showed other important effects of statins, such as antineoplastic action and improvement in endothelial function.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 化学(综合)
[关键词] statins;cholesterol;HMG-CoA reductase. [时效性] 
   浏览次数:9      统一登录查看全文      激活码登录查看全文